EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective

Alper Gümüş, Muhammed Emin Düz, Cihan Coşkun, Mustafa Velet, Macit Koldaş

Istanbul Medical Journal · 2019

DOI: 10.4274/imj.galenos.2018.04657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Istanbul Medical Journal, 2019. Verfasst von Alper Gümüş und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gümüş, A., Düz, M. E., Coşkun, C., Velet, M., & Koldaş, M. (2019). Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective. Istanbul Medical Journal. https://doi.org/10.4274/imj.galenos.2018.04657

Vancouver

Gümüş A, Düz ME, Coşkun C, Velet M, Koldaş M. Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective. Istanbul Medical Journal. 2019. doi:10.4274/imj.galenos.2018.04657

BibTeX
@article{Gm2019,
  author = {Gümüş, Alper and Düz, Muhammed Emin and Coşkun, Cihan and Velet, Mustafa and Koldaş, Macit},
  title = {Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective},
  journal = {Istanbul Medical Journal},
  year = {2019},
  doi = {10.4274/imj.galenos.2018.04657}
}
Kostenlos starten →